Literature DB >> 30471513

Antidiabetic and antihyperlipidemic effects of ethanolic Ferula assa-foetida oleo-gum-resin extract in streptozotocin-induced diabetic wistar rats.

Ebrahim Latifi1, Ahmad Ali Mohammadpour2, Behrooz Fathi H3, Hosein Nourani4.   

Abstract

The present study was conducted to investigate the hypoglycemic and hypolipidemic activity of ethanolic ferula assa-foetida oleo-gum-resin extract (FAOGRETE) and also its effects on liver and kidney function in streptozotocin (STZ)-induced diabetic rats. For this purpose, 42 male Wistar rats were divided into six groups (n = 7). Diabetes was induced in four groups by a single-dose of STZ at 55 mg/kg body weight, administrated intraperitoneal. After 42 days of treatment, fasting blood sugar (FBS) levels, serum insulin, biochemical parameters such as total cholesterol, triglycerides, low and high density lipoprotein cholesterol were measured. In addition the markers of liver and kidney function, such as glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, alkaline phosphatase, serum creatinine and urea levels were determined. The study showed that the ethanolic extract at 150 mg/kg body weight (b.w) had a significant antidiabetic activity after 42 days of treatment as the FBS levels decreased significantly while the serum insulin levels increased. Moreover, a significant decrease in the liver and kidney function markers in treated rats indicated the protective effect of the ethanolic extract against liver and kidney damage, while body weight increased. The serum concentrations were normal in normal control and healthy group treated with FAOGRETE. The results of this study showed that FAOGRETE can regulate hyperglycemia and complications of diabetes. Antidiabetic and hypolipidimic activities of FAOGRETE are probably related to its antioxidant activity. Phenolic and flavonoid compounds like ferulic acid, umbelliferone, and quercetin may play an important role in its mechanism of action.
Copyright © 2018 The Author. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Ferula assa-foetida; Hypoglycemia; Hypolipidemia; Insulin; Streptozotocin

Mesh:

Substances:

Year:  2018        PMID: 30471513     DOI: 10.1016/j.biopha.2018.10.152

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  Middle East Medicinal Plants in the Treatment of Diabetes: A Review.

Authors:  Alaa M Abu-Odeh; Wamidh H Talib
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

2.  Asafoetida exerts neuroprotective effect on oxidative stress induced apoptosis through PI3K/Akt/GSK3β/Nrf2/HO-1 pathway.

Authors:  Qianqian Huang; Chen Zhang; Shi Dong; Junwen Han; Sihao Qu; Tianshu Xie; Haibin Zhao; Yuanyuan Shi
Journal:  Chin Med       Date:  2022-07-06       Impact factor: 4.546

3.  Cytotoxic and Antimicrobial Efficacy of Silver Nanoparticles Synthesized Using a Traditional Phytoproduct, Asafoetida Gum.

Authors:  Sandhanasamy Devanesan; Karuppiah Ponmurugan; Mohamad S AlSalhi; Naif Abdullah Al-Dhabi
Journal:  Int J Nanomedicine       Date:  2020-06-19

4.  Extraction of Phenolic Compounds from Tabernaemontana catharinensis Leaves and Their Effect on Oxidative Stress Markers in Diabetic Rats.

Authors:  Rafael Sari; Paula Conterno; Leticia Dangui da Silva; Vanderlei Aparecido de Lima; Tatiane Luiza Cadorin Oldoni; Gustavo Roberto Thomé; Solange Teresinha Carpes
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

5.  Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies.

Authors:  Neeraj Choudhary; Gopal L Khatik; Rekha Sharma; Navneet Khurana; Richard Lobo; Shvetank Bhatt; Devesh Tewari; Ashish Suttee
Journal:  3 Biotech       Date:  2021-06-02       Impact factor: 2.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.